Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 164

    1.

    Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries.

    Fusco FM, Puro V, Baka A, Bannister B, Brodt HR, Brouqui P, Follin P, Gjorup IE, Gottschalk R, Hemmer R, Hoepelman IM, Jarhall B, Kutsar K, Lanini S, Lyytikainen O, Maltezou HC, Mansinho K, Marti MC, Ott K, Peleman R, Perronne C, Sheehan G, Siikamakii H, Skinhoj P, Trilla A, Vetter N, Ippolito G.

    J Hosp Infect. 2009 Sep;73(1):15-23. Epub 2009 Jul 31.PMID: 19647337 [PubMed - indexed for MEDLINE]Related articles

    2.

    Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis.

    Bani-Sadr F, Barange K, Daoud F, Jacomet C, Bicart-See A, Rosenthal E, Cacoub P, Pol S, Perronne C, Carrat F; ANRS HC02 - Ribavic Study Team.

    HIV Med. 2009 Aug;10(7):417-21. Epub 2009 Mar 26.PMID: 19490173 [PubMed - in process]Related articles

    3.

    Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02.

    Halfon P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Cacoub P.

    Antivir Ther. 2009;14(2):211-9.PMID: 19430096 [PubMed - indexed for MEDLINE]Related articles

    4.

    [The role of vaccination in the prevention of lower respiratory tract infections]

    Perronne C.

    Rev Mal Respir. 2009 Apr;26(4):475-7. French. No abstract available. PMID: 19421107 [PubMed - indexed for MEDLINE]Related articles

    5.

    Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease.

    Brouqui P, Puro V, Fusco FM, Bannister B, Schilling S, Follin P, Gottschalk R, Hemmer R, Maltezou HC, Ott K, Peleman R, Perronne C, Sheehan G, Siikamäki H, Skinhoj P, Ippolito G; EUNID Working Group.

    Lancet Infect Dis. 2009 May;9(5):301-11.PMID: 19393960 [PubMed - indexed for MEDLINE]Related articles

    6.

    Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy.

    Bani-Sadr F, Lapidus N, Rosenthal E, Gerard L, Foltzer A, Perronne C, Cacoub P, Pol S, Carrat F; and the ANRS HC02-Ribavic Study Team.

    J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):429-30. No abstract available. PMID: 19322037 [PubMed - indexed for MEDLINE]Related articles

    7.

    Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients?

    Bani-Sadr F, Bedossa P, Rosenthal E, Merrien D, Perre P, Lascoux-Combe C, Cacoub P, Perronne C, Pol S; ANRS HC02-Ribavic Study Team.

    J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):234-6. No abstract available. PMID: 19155771 [PubMed - indexed for MEDLINE]Related articles

    8.

    Efficacy of a long-term antibiotic treatment in patients with a chronic Tick Associated Poly-organic Syndrome (TAPOS).

    Clarissou J, Song A, Bernede C, Guillemot D, Dinh A, Ader F, Perronne C, Salomon J.

    Med Mal Infect. 2009 Feb;39(2):108-15. Epub 2009 Jan 4.PMID: 19124209 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prevention of urinary tract infection in six spinal cord-injured pregnant women who gave birth to seven children under a weekly oral cyclic antibiotic program.

    Salomon J, Schnitzler A, Ville Y, Laffont I, Perronne C, Denys P, Bernard L.

    Int J Infect Dis. 2009 May;13(3):399-402. Epub 2008 Nov 4.PMID: 18986822 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.

    Piroth L, Carrat F, Larrat S, Goderel I, Martha B, Payan C, Lunel-Fabiani F, Bani-Sadr F, Perronne C, Cacoub P, Pol S, Morand P.

    J Hepatol. 2008 Dec;49(6):892-8. Epub 2008 Jul 17.PMID: 18752863 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Current data on vaccines for respiratory diseases]

    Perronne C.

    Med Mal Infect. 2008 Aug;38(8):443-8. Epub 2008 Aug 22. French. PMID: 18722726 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Routine use of extended-release clarithromycin tablets for short-course treatment of acute exacerbations of non-severe COPD]

    Léophonte P, Zuck P, Perronne C, Baconnet B.

    Med Mal Infect. 2008 Sep;38(9):471-6. Epub 2008 Aug 21. French. PMID: 18722065 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Results of a prospective standardized study of 30 patients with chronic neurological and cognitive disorders after tick bites]

    Roche Lanquetot MO, Ader F, Durand MC, Carlier R, Defferriere H, Dinh A, Herrmann JL, Guillemot D, Perronne C, Salomon J.

    Med Mal Infect. 2008 Oct;38(10):543-8. French. PMID: 18722064 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Hepatitis C: which strategy in case of treatment failure ?]

    Bronowicki JP, Larrey D, Tran A, Perronne C, Denis J, Cadranel JF, Trépo C.

    Gastroenterol Clin Biol. 2008 Mar;32(3 Pt 2):S109-16. Review. French. PMID: 18675180 [PubMed - indexed for MEDLINE]Related articles

    15.

    Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients.

    Carrat F, Bedossa P, Lunel-Fabiani F, Morand P, Pialoux G, Piroth L, Salmon-Céron D, Bani-Sadr F, Perronne C, Cacoub P, Pol S.

    AIDS. 2008 Jul 31;22(12):1513-5.PMID: 18614875 [PubMed - indexed for MEDLINE]Related articles

    16.

    Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.

    Bani-Sadr F, Goderel I, Lapidus N, Driss H, Simon A, Rosenthal E, Morand P, Lunel-Fabiani F, Pol S, Cacoub P, Perronne C, Carrat F; ANRS HC02 - RIBAVIC Study Team.

    AIDS. 2008 Jul 11;22(11):1385-7. No abstract available. PMID: 18580626 [PubMed - indexed for MEDLINE]Related articles

    17.

    Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients.

    Bani-Sadr F, Miailhes P, Rosenthal E, Yazdanpanah Y, Boyer L, Zucman D, Cacoub P, Perronne C, Pol S, Carrat F; ANRS HC02 - Ribavic Study Team.

    AIDS. 2008 Jun 19;22(10):1234-6. No abstract available. PMID: 18525274 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Profile and management of patients consulting for a non severe exacerbation of chronic obstructive pulmonary disease (Pragma survey)]

    Léophonte P, Zuck P, Perronne C.

    Med Mal Infect. 2008 Apr;38(4):200-7. Epub 2008 Mar 12. French. PMID: 18339501 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.

    Cacoub P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Halfon P.

    J Hepatol. 2008 May;48(5):765-73. Epub 2008 Feb 14.PMID: 18314219 [PubMed - indexed for MEDLINE]Related articles

    20.

    Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors.

    Bani-Sadr F, Lapidus N, Melchior JC, Ravaux I, Bensalem M, Rosa I, Cacoub P, Pol S, Perronne C, Carrat F.

    J Viral Hepat. 2008 Apr;15(4):255-60.PMID: 18307589 [PubMed - indexed for MEDLINE]Related articles

    21.

    Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.

    Bani-Sadr F, Lapidus N, Bedossa P, De Boever CM, Perronne C, Halfon P, Pol S, Carrat F, Cacoub P; French National Agency for Research on AIDS; Viral Hepatitis-HC02-Ribavic Study Team.

    Clin Infect Dis. 2008 Mar 1;46(5):768-74.PMID: 18248298 [PubMed - indexed for MEDLINE]Related articles

    22.

    The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice.

    Villes V, Spire B, Lewden C, Perronne C, Besnier JM, Garré M, Chêne G, Leport C, Carrieri MP, Le Moings V; ANRS CO-8 APROCO-COPILOTE Study Group.

    Antivir Ther. 2007;12(7):1067-74.PMID: 18018765 [PubMed - indexed for MEDLINE]Related articles

    23.

    [Management of HCV-HIV patients]

    Pol S, Cacoub P, Pialoux G, Benhamou Y, Halfon P, Rosenthal E, Perronne C.

    Gastroenterol Clin Biol. 2007 Aug-Sep;31(8-9 Pt 3):4S7-12. Review. French. PMID: 17965629 [PubMed - indexed for MEDLINE]Related articles

    24.

    Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006.

    Cacoub P, Halfon P, Rosenthal E, Pialoux G, Benhamou Y, Perronne C, Pol S; Prospecth Study Group.

    J Hepatol. 2008 Jan;48(1):35-42. Epub 2007 Oct 2.PMID: 17945375 [PubMed - indexed for MEDLINE]Related articles

    25.

    Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.

    Bani-Sadr F, Goderel I, Penalba C, Billaud E, Doll J, Welker Y, Cacoub P, Pol S, Perronne C, Carrat F; ANRS HC02 - Ribavic Study team.

    J Viral Hepat. 2007 Sep;14(9):639-44.PMID: 17697016 [PubMed - indexed for MEDLINE]Related articles

    26.

    Familial occurrence of cat-scratch disease, with varying clinical expression.

    Song AT, Gory M, Roussi J, Salomon J, Cremieux AC, Perronne C, Bernard L.

    Scand J Infect Dis. 2007;39(8):728-30.PMID: 17654352 [PubMed - indexed for MEDLINE]Related articles

    27.

    High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?

    Bani-Sadr F, Goderel I, Morand P, Payan C, Lunel F, Pol S, Perronne C, Carrat F, Cacoub P.

    AIDS. 2007 Jul 31;21(12):1645-8.PMID: 17630563 [PubMed - indexed for MEDLINE]Related articles

    28.

    Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?

    Bani-Sadr F, Denoeud L, Morand P, Lunel-Fabiani F, Pol S, Cacoub P, Perronne C, Carrat F; Agence Nationale pour la Recherche contre le SIDA et les Hépatites Virales HC02-Ribavic Study Team.

    J Acquir Immune Defic Syndr. 2007 May 1;45(1):123-5. No abstract available. PMID: 17460476 [PubMed - indexed for MEDLINE]Related articles

    29.

    Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients.

    Payan C, Pivert A, Morand P, Fafi-Kremer S, Carrat F, Pol S, Cacoub P, Perronne C, Lunel F; ANRS HC02 RIBAVIC study team.

    Gut. 2007 Aug;56(8):1111-6. Epub 2007 Mar 15.PMID: 17363475 [PubMed - indexed for MEDLINE]Related articles

    30.

    Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study).

    Rosenthal E, Pialoux G, Bernard N, Pradier C, Rey D, Bentata M, Michelet C, Pol S, Perronne C, Cacoub P; GERMIVIC Joint Study Group.

    J Viral Hepat. 2007 Mar;14(3):183-8.PMID: 17305884 [PubMed - indexed for MEDLINE]Related articles

    31.

    A novel X-linked recessive form of Mendelian susceptibility to mycobaterial disease.

    Bustamante J, Picard C, Fieschi C, Filipe-Santos O, Feinberg J, Perronne C, Chapgier A, de Beaucoudrey L, Vogt G, Sanlaville D, Lemainque A, Emile JF, Abel L, Casanova JL.

    J Med Genet. 2007 Feb;44(2):e65.PMID: 17293536 [PubMed - indexed for MEDLINE]Related articles

    32.

    Hypervirulence of a rough variant of the Mycobacterium abscessus type strain.

    Catherinot E, Clarissou J, Etienne G, Ripoll F, Emile JF, Daffé M, Perronne C, Soudais C, Gaillard JL, Rottman M.

    Infect Immun. 2007 Feb;75(2):1055-8. Epub 2006 Dec 4.PMID: 17145951 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    B-cell immune responses in HIV positive and HIV negative patients with tuberculosis evaluated with an ELISA using a glycolipid antigen.

    Simonney N, Chavanet P, Perronne C, Leportier M, Revol F, Herrmann JL, Lagrange PH.

    Tuberculosis (Edinb). 2007 Mar;87(2):109-22. Epub 2006 Oct 6.PMID: 17030018 [PubMed - indexed for MEDLINE]Related articles

    34.

    Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.

    Cacoub P, Rosenthal E, Halfon P, Sene D, Perronne C, Pol S.

    J Viral Hepat. 2006 Oct;13(10):678-82.PMID: 16970599 [PubMed - indexed for MEDLINE]Related articles

    35.

    Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

    Bresson JL, Perronne C, Launay O, Gerdil C, Saville M, Wood J, Höschler K, Zambon MC.

    Lancet. 2006 May 20;367(9523):1657-64.PMID: 16714186 [PubMed - indexed for MEDLINE]Related articles

    36.

    [Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections]

    Galpérine T, Ader F, Piriou P, Judet T, Perronne C, Bernard L.

    Med Mal Infect. 2006 Mar;36(3):132-7. Epub 2006 Mar 31. Review. French. PMID: 16580802 [PubMed - indexed for MEDLINE]Related articles

    37.

    Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up--an observational prospective study.

    Salomon J, Denys P, Merle C, Chartier-Kastler E, Perronne C, Gaillard JL, Bernard L.

    J Antimicrob Chemother. 2006 Apr;57(4):784-8. Epub 2006 Feb 10.PMID: 16473921 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.

    Bani-Sadr F, Carrat F, Bedossa P, Piroth L, Cacoub P, Perronne C, Degott C, Pol S; ANRS HC02 - Ribavic Study team.

    AIDS. 2006 Feb 28;20(4):525-31.PMID: 16470116 [PubMed - indexed for MEDLINE]Related articles

    39.

    Comparison of serum hepatitis C virus (HCV) RNA and core antigen levels in patients coinfected with human immunodeficiency virus and HCV and treated with interferon plus ribavirin.

    Pivert A, Payan C, Morand P, Fafi-Kremer S, Deshayes J, Carrat F, Pol S, Cacoub P, Perronne C, Lunel F.

    J Clin Microbiol. 2006 Feb;44(2):417-22.PMID: 16455894 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    [Infectious diseases risk management]

    Salomon J, Guillemot D, Bernard L, Perronne C.

    Rev Prat. 2005 Nov 30;55(18):2003-13. Review. French. PMID: 16419905 [PubMed - indexed for MEDLINE]Related articles

    41.

    Antiviral hepatitis and antiretroviral drug interactions.

    Perronne C.

    J Hepatol. 2006;44(1 Suppl):S119-25. Epub 2005 Dec 1. Review.PMID: 16360231 [PubMed - indexed for MEDLINE]Related articles

    42.

    [Cervical spondylodiscitis: one pathogen may hide another]

    Toubiana J, Salomon J, Ader F, Perronne C, Carlier R, Bernard L.

    Med Mal Infect. 2006 Jan;36(1):55-7. Epub 2005 Nov 23. French. PMID: 16309869 [PubMed - indexed for MEDLINE]Related articles

    43.

    Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment.

    Bani-Sadr F, Carrat F, Rosenthal E, Piroth L, Morand P, Lunel-Fabiani F, Bonarek M, Colin de Verdiere N, Pialoux G, Cacoub P, Pol S, Perronne C; ANRS HC02-Ribavic Study Team.

    Clin Infect Dis. 2005 Dec 15;41(12):1806-9. Epub 2005 Nov 11.PMID: 16288408 [PubMed - indexed for MEDLINE]Related articles

    44.

    [Efficacy and safety of extended-release clarithromycin (5-day short-course) vs telithromycin, in acute bacterial exacerbation of chronic bronchitis]

    Perronne C, Drugeon H, Zuck P, Filipecki J, Vincent-Lacaze N, Goldfarb G, Léophonte P.

    Med Mal Infect. 2005 Oct;35(10):507-15. Epub 2005 Oct 18. French. PMID: 16239090 [PubMed - indexed for MEDLINE]Related articles

    45.

    Workshop report treating hepatitis C in HIV-infected patients: where are we now?

    Perronne C.

    Antivir Ther. 2005;10(5):691-4.PMID: 16152763 [PubMed - indexed for MEDLINE]Related articles

    46.

    Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy.

    Bani-Sadr F, Carrat F, Pol S, Hor R, Rosenthal E, Goujard C, Morand P, Lunel-Fabiani F, Salmon-Ceron D, Piroth L, Pialoux G, Bentata M, Cacoub P, Perronne C; ANRS Hc02-Ribavic Study Team.

    J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):47-52.PMID: 16123681 [PubMed - indexed for MEDLINE]Related articles

    47.

    [Intolerance to and/or drug interactions of anti-HIV and anti-HVC therapy]

    Galpérine T, Merle C, de Truchis P, Bernard L, Perronne C.

    Med Mal Infect. 2005 Mar;35(3):135-40. Review. French. PMID: 15911183 [PubMed - indexed for MEDLINE]Related articles

    48.

    Management of chronic hepatitis C in French departments of internal medicine and infectious diseases.

    Cacoub P, Goderel I, Morlat P, Sene D, Myers RP, Alric L, Loustaud-Ratti V, Melin P, Limal N, Ouzan D, Perronne C, Carrat F; GERMIVIC Group.

    Epidemiol Infect. 2005 Apr;133(2):305-14.PMID: 15816156 [PubMed - indexed for MEDLINE]Related articles

    49.

    HIV and hepatitis C virus co-infection.

    Carrat F, Perronne C; ANRS HC02-RIBAVIC study team.

    Lancet Infect Dis. 2005 Feb;5(2):71. No abstract available. PMID: 15680774 [PubMed - indexed for MEDLINE]Related articles

    50.

    [Is bone infection of endogenous or exogenous origin? A pathophysiological approach]

    Ader F, Salomon J, Perronne C, Bernard L.

    Med Mal Infect. 2004 Nov;34(11):530-7. Review. French. PMID: 15620057 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...